Search found 531 matches

by Fishermangents
Thu Dec 10, 2015 3:43 pm
Forum: ImetelChat
Topic: Take aways from Oppenheimer
Replies: 6
Views: 5284

Re: Take aways from Oppenheimer

Phil: agree with your observation. Dr. Scarlett didn't become too frenzy about it, probably because formally TI is not primary end point. But he clearly stated that they will measure everything they could in order to indicate the depth and nature of the responses. Clearly TI is a major one, in fact ...
by Fishermangents
Thu Dec 10, 2015 9:23 am
Forum: ImetelChat
Topic: Welcome!
Replies: 0
Views: 3180

Welcome!

Dear all, thanks for joining this board. I highly value you as being members of the first hour! We'll try to keep this MB clean and honest. Hopefully it will become a place where people with various interests and backgrounds feel comfortable. There are some things that are important in making this p...
by Fishermangents
Wed Dec 09, 2015 6:33 pm
Forum: ImetelChat
Topic: Take aways from Oppenheimer
Replies: 6
Views: 5284

Take aways from Oppenheimer

- IMerge contains already a Phase 3 protocol. The primary outcome is TI. IMegre is intended clearly as a registration enabling study. Expecting to see significant proportion of TI as well as symptomatic improvement. - the decisive argument for Tefferi as well as JnJ to put their cards on imetelstat ...
by Fishermangents
Wed Dec 09, 2015 4:14 pm
Forum: ImetelChat
Topic: Fisher, you did it!!
Replies: 6
Views: 5117

Re: Fisher, you did it!!

Thanks for registering, Phil! Please feel free to provide your opinions and views here!
by Fishermangents
Wed Dec 09, 2015 2:32 pm
Forum: ImetelChat
Topic: Zacks: Geron’s telomerase technology platform represents significant commercial opportunity
Replies: 0
Views: 3448

Zacks: Geron’s telomerase technology platform represents significant commercial opportunity

Zacks, 8 Dec 2015: Geron’s telomerase technology platform represents significant commercial opportunity. The successful development of products that target telomeres could very well change the treatment paradigm for several diseases including oncology, which represents significant commercial potenti...
by Fishermangents
Wed Dec 09, 2015 1:44 pm
Forum: ImetelChat
Topic: Dr. Titia de Lange from the Rockefeller University Institute about telomeres and telomerase; very nice explanation
Replies: 0
Views: 3508

Dr. Titia de Lange from the Rockefeller University Institute about telomeres and telomerase; very nice explanation

Dr. Titia de Lange from the Rockefeller University Institute Australia speaks about telomeres and telomerase (recorded 30 May 2015). It is very nice and clear explanation. She speaks about the mechanisms of telomerase, including ageing. On 21.13 she elaborates on telomerase inhibition as a cancer th...
by Fishermangents
Wed Dec 09, 2015 10:01 am
Forum: ImetelChat
Topic: Fisher, you did it!!
Replies: 6
Views: 5117

Re: Fisher, you did it!!

Hi BioPearl, thanks for registering and your supportive post. I hope this board will have good discussions and contributions. I will check DewDillegence as you suggest. I am looking forward to see how this board will evolve. Patients, investors, doctors and anyone interested should be safe and comfo...
by Fishermangents
Tue Dec 08, 2015 1:21 pm
Forum: ImetelChat
Topic: Take aways from ASH2015
Replies: 1
Views: 2363

Take aways from ASH2015

by sdrawkcabeman (repost from Yahoo MB, 6 Dec 2015 1:12 PM) Points to drive home from the presentation The emphasis and growing chorus is that there’s a serious unmet need for MF/MDS/AML pts, and that’s the big push coalescing behind Imet. In the Q&A Dr. Baerlocher, Dr. Burington, Dr. Scarlett all s...
by Fishermangents
Mon Dec 07, 2015 7:14 pm
Forum: ImetelChat
Topic: Piper Jaffrey raised Geron's price target from $5 to $10
Replies: 0
Views: 3436

Piper Jaffrey raised Geron's price target from $5 to $10

7 Dec 2015 Piper Jaffray on Monday issued a company note on Geron Corporation (NASDAQ: GERN) after news of new drug developments at the ASH 2015 conference. Piper Jaffray rates Geron as Overweight and raised the company's price target from $5.00 to $10.00. Analysts Charles Duncan and Sarah Weber wro...
by Fishermangents
Sat Dec 05, 2015 2:00 pm
Forum: ImetelChat
Topic: IMerge recruiting in US and Netherlands
Replies: 0
Views: 3523

IMerge recruiting in US and Netherlands

MDS trial IMerge (34 locations) is no recruiting at two locations: Bethesda (Maryland, US) and Groningen (Netherlands). From the clinical trials site: Updated Nov. 30th Clinical Trials Identifier: NCT02598661 ( imetelstat Phase 2/3 ) Now Recruiting 2 locations - Recruiting Bethesda, Maryland, United...
by Fishermangents
Fri Dec 04, 2015 2:21 pm
Forum: ImetelChat
Topic: Geron CEO to speak at Oppenheimer 9 Dec 2015
Replies: 1
Views: 2792

Geron CEO to speak at Oppenheimer 9 Dec 2015

John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at Oppenheimer 26th Annual Healthcare Conference in New York at 9:45 a.m. ET on December 9, 2015. The live and archived webcast will be available at http://www.veracast.com/webcasts/opco/healthcare2015/84203554236...